The US FDA has recently proposed a new draft framework that enables pharma manufacturers to add software to a drug label if they can demonstrate that the software adds clinical benefit to the drug.
"How do you drive super-fan engagement? How do you monetize it? Let’s give the fans a better experience," says 237 Global founder Mark Weiss. "That experience will translate into more revenue and more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results